Human Urine–Derived Induced Pluripotent Stem Cell Membranes Enable Personalized Transdermal Nanotherapy for Melanoma
ACS Nano · 10.11.2026 · 20 (44) · 29420-29434
DOI: 10.1021/acsnano.6c05279 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 02.11.2026. Verfasst von Dasong Hong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical & Biomolecular Engineering, College of Engineering, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul03722, Republic of Kor…. Hauptthemen laut MEDLINE: Melanoma, Induced Pluripotent Stem Cells, Cell Membrane, Antineoplastic Agents. Die Arbeit nennt 47 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Melanoma treatment remains limited by drug resistance, immune-related adverse effects, and inadequate tumor-specific drug delivery. Nanoparticle (NP)-based delivery platforms have shown promise, but their clinical translation is hindered by rapid immune clearance and suboptimal biocompatibility. Current membrane-coating strategies often depend on invasive cell sources and lack patient-specific applicability. This study introduces a personalized melanoma therapy platform that integrates MnO2 NPs (MNPs) coated with urine-derived induced pluripotent stem cell (iPSC) membranes into a hydrogel-based transdermal patch. The patient-derived iPSC membrane enhances tumor targeting and immune evasion through the CXCR4/CXCL12 axis, while the MNPs facilitate pH-responsive release of cytotoxic drugs within the tumor microenvironment, maximizing therapeutic efficacy. The hydrogel transdermal patch enables direct, noninvasive delivery to skin lesions, promoting sustained drug exposure and potentially improving patient compliance. By combining autologous cell membrane coating, pH-responsive nanocarriers, and transdermal administration, this platform addresses key limitations of current melanoma therapies and supports the potential for clinical translation of personalized nanomedicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical & Biomolecular Engineering, College of Engineering, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul03722, Republic of Korea.
- Department of Biomedical Science, Kangwon National University, Chuncheon, Gangwon-do24341, Republic of Korea.
- Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul03722, Republic of Korea.
- School of Mechanical Engineering, Chung-Ang University, 84, Heukseok-Ro, Dongjak-gu, Seoul06974Republic of Korea.
ORCID-Profile: Taihyun Kim, Juhyun Park, Won-Gun Koh, Sangmin Lee, Jinkee Hong
Förderung
- National Research Foundation of Korea
Zitieren
APA
Hong, D., Kim, T., Heo, S. E., Kim, M., Park, J., Moon, C. W., Ha, S. J., Koh, W. G., Lee, S., & Hong, J. (2026). Human Urine–Derived Induced Pluripotent Stem Cell Membranes Enable Personalized Transdermal Nanotherapy for Melanoma. ACS Nano, 20(44), 29420-29434. https://doi.org/10.1021/acsnano.6c05279
Vancouver
Hong D, Kim T, Heo SE, Kim M, Park J, Moon CW, et al. Human Urine–Derived Induced Pluripotent Stem Cell Membranes Enable Personalized Transdermal Nanotherapy for Melanoma. ACS Nano. 2026;20(44):29420-29434. doi:10.1021/acsnano.6c05279
BibTeX
@article{Hong2026,
author = {Hong, Dasong and Kim, Taihyun and Heo, Sung-Eun and Kim, Manho and Park, Juhyun and Moon, Chae-Won and Ha, Sang-Jun and Koh, Won-Gun and Lee, Sangmin and Hong, Jinkee},
title = {Human Urine–Derived Induced Pluripotent Stem Cell Membranes Enable Personalized Transdermal Nanotherapy for Melanoma},
journal = {ACS Nano},
year = {2026},
volume = {20},
number = {44},
pages = {29420--29434},
doi = {10.1021/acsnano.6c05279}
}
EUVIMED